Lavipharm

Lavipharm is a publicly traded Greek pharmaceutical company with a diversified portfolio spanning prescription, OTC, and nutraceutical products. Driven by innovation, it focuses on key therapeutic areas such as cardiology, CNS, and oncology to provide improved healthcare solutions. The company leverages its in-house R&D and manufacturing capabilities to serve the Greek and international markets, operating as a fully integrated commercial-stage entity.

Integrated pharmaceutical company with in-house R&D, manufacturing, and commercialization capabilities, focused on formulation development and lifecycle management of small molecule drugs.

Competes with large multinational pharma companies and other regional generic/specialty pharma firms in Greece and abroad. Differentiation is sought through product innovation, lifecycle management, and a diversified portfolio across prescription and consumer health.